Mycronic AB
Sweden · SE0000375115 · reports in SEK · Europe
The answers
From the annual report for the year to Dec 31, 2024. Each line says what it is based on.
- Is it growing?Good
- Revenue +24% in the year to Dec 31, 2024, on the year before.
- Is it a good business?Good
- It earned 26% on its shareholders' equity in the year to Dec 31, 2024.
- Is it safe?Good
- Equity is 63% of its assets, and operations brought in cash in the year.
- Is the price fair?n/a
- Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.
The year
Year to Dec 31, 2024, consolidated, in SEK.
SEK 7.1B
revenue
29%
operating margin
SEK 1.7B
net profit
Year by year
As filed; an earlier year can differ from its own report when the company restated it.
| Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|
| Revenue | SEK 4.6B | SEK 5.1B | SEK 5.7B | SEK 7.1B |
| Operating profit | SEK 1.0B | SEK 894M | SEK 1.2B | SEK 2.0B |
| Net profit to shareholders | SEK 828M | SEK 741M | SEK 998M | SEK 1.7B |
| Dividend per share | n/a | SEK 3.50 | n/a | SEK 4.50 |
| Cash from operations | SEK 998M | SEK 853M | SEK 1.6B | SEK 1.9B |
| Capital spending | SEK 42M | SEK 107M | SEK 103M | SEK 126M |
| Cash | SEK 683M | SEK 1.3B | SEK 2.1B | SEK 3.0B |
| Total assets | SEK 6.1B | SEK 7.3B | SEK 8.3B | SEK 10.4B |
| Equity | SEK 4.0B | SEK 4.7B | SEK 5.3B | SEK 6.6B |
What they do
In the company's own words, from the annual report.
utveckling, tillverk ning och försäljning av avancerad produktions utrustning till elektronikindustrin.
Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the answers and ratios from the filed figures.